Sydney, Oct 16, 2007 (ABN Newswire) - Starpharma Holdings Limited (ASX: SPL) - Co-development Agreement with Durex for Condoms with VivaGel - Dr Jackie Fairley, CEO; Starpharma Holdings Limited (ASX: SPL) present the following audio webcast regarding "Co-development Agreement with Durex for Condoms with VivaGel". You may also download this audio webcast to your computer or portable audio player.
Broadcast Title: Co-development Agreement with Durex for Condoms with VivaGel
Broadcast Type: Audio stream
Audio webcast Link:
Listen to the Audio stream and view the announcement for Starpharma Holdings Limited (ASX: SPL) below.
http://abnnewswire.net/vlnk/1O5W2CLQ
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Minimum requirement for playing the multimedia links are; at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player. In addition, some media links contain material requiring the ability to run Flash Multimedia.
About STARPHARMA HOLDINGS LIMITED
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc in Michigan, USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents.
The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.